|
FAM120AOS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32030000000472E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.88999999999729E-05 |
| Normal-vs-Stage2 |
6.116100E-02 |
| Normal-vs-Stage3 |
1.490030E-02 |
| Normal-vs-Stage4 |
6.965900E-02 |
| Stage1-vs-Stage2 |
5.511400E-01 |
| Stage1-vs-Stage3 |
6.737200E-01 |
| Stage1-vs-Stage4 |
6.073800E-01 |
| Stage2-vs-Stage3 |
8.217600E-01 |
| Stage2-vs-Stage4 |
9.424600E-01 |
| Stage3-vs-Stage4 |
7.902800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.02510000000867E-05 |
| Normal-vs-AfricanAmerican |
4.461200E-03 |
| Normal-vs-Asian |
1.138300E-03 |
| Caucasian-vs-AfricanAmerican |
5.838400E-01 |
| Caucasian-vs-Asian |
3.213200E-01 |
| AfricanAmerican-vs-Asian |
1.348630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37390000001891E-06 |
| Normal-vs-Female |
9.802400E-02 |
| Male-vs-Female |
2.964400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.381900E-03 |
| Normal-vs-Extreme_Weight |
3.81879999999946E-05 |
| Normal-vs-Obese |
3.998000E-02 |
| Normal-vs-Extreme_Obese |
7.827100E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.316600E-01 |
| Normal_Weight-vs-Obese |
4.379200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.507600E-01 |
| Extreme_Weight-vs-Obese |
1.197620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.592600E-01 |
| Obese-vs-Extreme_Obese |
2.119200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.183700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.787600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.93239999954653E-07 |
| Normal-vs-Age(81-100Yrs) |
2.556400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.574400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.941200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.856200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.704600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.574400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.921000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.156290E-04 |
| Normal-VS-Type2 PRCC |
3.724500E-03 |
| Normal-VS-KIRP CIMP |
9.340000E-01 |
| Normal-VS-Unclassified PRCC |
1.239180E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.897200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.264760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.154600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.219200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.145000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.475800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.230800E-04 |
| Normal-vs-N1 |
1.726180E-01 |
| Normal-vs-N2 |
7.618700E-03 |
| N0-vs-N1 |
2.100200E-01 |
| N0-vs-N2 |
6.933000E-01 |
| N1-vs-N2 |
3.312400E-01 |
|
|
